Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / RARX - RARX WMGI IBKC: Monteverde & Associates PC Continues Legal Inquiry Regarding the Buyout


RARX - RARX WMGI IBKC: Monteverde & Associates PC Continues Legal Inquiry Regarding the Buyout

NEW YORK, NY / ACCESSWIRE / November 21, 2019 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

  • Ra Pharmaceuticals, Inc. (NASDAQ:RARX) related to its sale to UCB S.A. Under the terms of the agreement, each share of RARX common stock will be converted into the right to receive $48.00 in cash per share of RARX common stock owned. The transaction value is expected to be approximately $2.1 billion. Click here for more information: https://www.monteverdelaw.com/case/ra-pharmaceuticals-inc. It is free and there is no cost or obligation to you.
  • Wright Medical Group N.V. (NASDAQ:WMGI) related to its purchase agreement with Stryker Corporation. Under the terms of the transaction, Wright Medical Group shareholders will have the right to receive $30.75 in cash for each Wright Medical Group shares owned. Click here for more information: https://www.monteverdelaw.com/case/wright-medical-group-nv. It is free and there is no cost or obligation to you.
  • IBERIABANK Corporation (NASDAQ:IBKC) related to its sale to First Horizon National Corporation. Under the terms of the merger agreement, each share of IBKC common stock will be converted into the right to receive 4.584 shares of First Horizon common stock for each IBKC common stock owned. Click here for more information: https://www.monteverdelaw.com/case/iberiabank-corporation. It is free and there is no cost or obligation to you.


Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/567626/RARX-WMGI-IBKC-Monteverde-Associates-PC-Continues-Legal-Inquiry-Regarding-the-Buyout

Stock Information

Company Name: Ra Pharmaceuticals Inc.
Stock Symbol: RARX
Market: NASDAQ
Website: rapharma.com

Menu

RARX RARX Quote RARX Short RARX News RARX Articles RARX Message Board
Get RARX Alerts

News, Short Squeeze, Breakout and More Instantly...